Literature DB >> 6811658

The human HLA-DR antigens are encoded by multiple beta-chain loci.

C K Hurley, G Nunez, R Winchester, O J Finn, R Levy, J D Capra.   

Abstract

Monoclonal antibodies have been used to isolate and characterize human HLA-DR antigens from human B cell lines. Using sequential immunodepletion experiments, several subsets of DR antigens have been identified. Partial amino-terminal amino acid sequencing has identified these subsets as DR molecules with sequences homologous to the murine I-E alloantigens. In addition, sequence data provide evidence for primary structural differences in the DR beta-chains of two of the subsets. These results provide primary structural evidence for the presence of multiple DR beta-chain loci.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6811658

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Recognition of class II molecules by human T cells. I. Analysis of epitopes of DR and DQ molecules in a DRw11, DRw52, DQw3 haplotype.

Authors:  L K Myers; E J Ball; G Nuñez; P Stastny
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Polymorphisms within the HLA-DR3 haplotypes. I. HLA-DR polymorphisms detected at the protein and DNA levels are reflected by T-cell recognition.

Authors:  R Bontrop; M Tilanus; M Mikulski; M van Eggermond; A Termijtelen; M Giphart
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes.

Authors:  L Matera; R Foa; M Massaia; M Giovarelli; F Veglia; A Cesano; P Lusso; A Piazza; D Santoli
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

4.  Characterization of an HLA DR beta pseudogene.

Authors:  D Larhammar; B Servenius; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion.

Authors:  R C Giles; R DeMars; C C Chang; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  Functional subdivision of HLA-DRw8 with influenza-specific cloned cell lines.

Authors:  Y Henin; G Sterkers; E Gomard; L Gebuhrer; A C Freidel; V Lepage; M H Stern; J Michon; H Betuel; J P Levy
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

7.  Molecular characterization of a subtype of DQw1 recognized by hapten-specific T cells.

Authors:  J H Hanke; R G Cook; J W Leone; M Van; R R Rich
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

8.  Primary structural sequence polymorphism in the human class II MHC antigen 33.1.

Authors:  M C Kuo; X M Li; G E Marti; J A Sachs; J A Sogn; J E Coligan; T J Kindt
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.

Authors:  Rajesh Singh; Shailesh Singh; Praveen K Sharma; Udai P Singh; David E Briles; Susan K Hollingshead; James W Lillard
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

10.  Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope.

Authors:  S Seremetis; J Cuttner; R Winchester
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.